Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 94 clinical trials
Intratumoral Injection of LTX-315 in Combination With Pembrolizumab in Advanced Melanoma (ATLAS-IT-05)

ATLAS-IT-05 is an open-label, single-arm study in patients with advanced melanoma accessible for injections (cutaneous, subcutaneous, lymph node, or intramuscular tumors) and who have either

  • 0 views
  • 18 May, 2022
  • 2 locations
CMP-001 in Combination With Nivolumab Compared to Nivolumab Monotherapy in Subjects With Advanced Melanoma

CMP-001-011 is a Phase 2/3 study of CMP-001 intratumoral (IT) and nivolumab intravenous (IV) compared to nivolumab monotherapy administered to participants with unresectable or metastatic melanoma. The study is divided into two phases: Phase 2 and Phase 3. The primary objective of Phase 2 of the study is to determine …

advanced melanoma
nivolumab
metastatic melanoma
  • 0 views
  • 18 May, 2022
  • 20 locations
Phase II Study in the Treatment of Patients With Advanced Mucinous Melanoma (BJCH-MM-0624)

This is a randomized, controlled, multicenter Phase II clinical study to evaluate the efficacy and safety of toripalimab injection combined with axitinib in the first-line treatment of patients with advanced mucosal melanoma. The target population is the patients with previously untreated, histopathologically confirmed, unresectable or metastatic mucosal melanoma. At the …

  • 1 views
  • 06 Feb, 2022
  • 1 location
APX005M With Nivolumab and Cabiralizumab in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell Carcinoma

This trial is a phase 1/1b study to evaluate the safety, efficacy, and tolerability of APX005M in combination with nivolumab and cabiralizumab. The phase 1 dose escalation portion of the study will enroll patients with advanced solid tumors melanoma, non-small cell lung cancer (NSCLC), and renal cell carcinoma (RCC) in …

tyrosine
EGFR
osimertinib
brain metastasis
cabiralizumab
  • 42 views
  • 12 Mar, 2022
  • 1 location
Tocilizumab Ipilimumab and Nivolumab for the Treatment of Advanced Melanoma Non-Small Cell Lung Cancer or Urothelial Carcinoma

This phase II trial investigates the side effects of tocilizumab, ipilimumab, and nivolumab in treating patients with melanoma, non-small cell lung cancer, or urothelial carcinoma that has spread to nearby tissue or lymph nodes (locally advanced). Immunotherapy with monoclonal antibodies, such as ipilimumab and nivolumab, may help the body's immune …

  • 0 views
  • 04 Oct, 2021
  • 1 location
Fecal Microbial Transplantation Non-Small Cell Lung Cancer and Melanoma (FMT-LUMINATE)

The aim of this study is to assess the anti-tumor activity of FMT administered in combination with ICI therapy.

  • 0 views
  • 29 Jun, 2022
  • 2 locations
A Study of APX005M in Combination With Nivolumab and Ipilimumab in Treatment Na ve Patients With Advanced Melanoma or Renal Cell Carcinoma (RCC)

ipilimumab in patients with advanced melanoma and RCC.

targeted therapy
urine test
major surgery
nivolumab
ipilimumab
  • 0 views
  • 12 Nov, 2021
  • 2 locations
Combination of Temozolomide and Sunitinib in Treatment of Patients With Metastatic and Unresectable Malignant Melanoma

, sunitinib malate in patients with advanced melanoma..

temozolomide
advanced melanoma
  • 23 views
  • 07 Nov, 2020
  • 1 location
MAGE-C2 TCR T Cell Trial to Treat Melanoma and Head and Neck Cancer (MC2TCR)

Single-centre, first-in-man phase I/II trial to demonstrate safety and efficacy of MAGE-C2/HLA-A2 TCR T cells (MC2 TCR T cells) in advanced melanoma (MEL) and head-and-neck carcinoma (HNSCC).

  • 4 views
  • 13 Jun, 2022
  • 1 location
Neoadjuvant Immunotherapy With Tavo + Electroporation in Combination With Nivo. in Melanoma Patients

operable locally-regionally advanced melanoma.

measurable disease
advanced melanoma
nivolumab
ct scan
metastasis
  • 20 views
  • 17 Jun, 2022
  • 1 location